Article Listing - Novartis and Vectura’s NVA237 filed in Europe; positive Ph III data at ERS; Gilenya, Ilaris approved in Japan

PIERRE FABRE ON EXPANSION TRAIL

23 March 1992

The second largest independent French drugs group, Pierre Fabre, is to give priority to research and development in order to...

HOECHST ON DRUG DEV'T ECONOMIC PRESSURES

23 March 1992

The pharmaceutical division of German chemicals major Hoechst AG has been completely reorganized to enable the company to react more...

PRICE SET FOR ELF AQUITAIN FLOAT

23 March 1992

The French goverment has set the price for the sale of a 2.3% stake in Elf Aquitaine, which controls the...

CUROSURF LICENSING DEAL

23 March 1992

Switzerland's Ares-Serono Group and Parma, Italy-based Chiesi Farma-ceutici have announced an agreement in which the former acquires exclusive rights to...

TEN YEARS OF ACE INHIBITION

23 March 1992

The news that the US Food and Drug Administration has requested six manufacturers of ACE in-hibitors to put stronger warning...

ESTRAPAK FOR OSTEOPOROSIS IN UK

23 March 1992

Ciba-Geigy's transdermal hormone replacement therapy Estrapak 50, which combines an estrogen patch and progestogen tablets for endometrial protection, is now...

WORLD NEWS IN BRIEF

23 March 1992

- In China, the State Statistical Bureau reports that prices of medicines and medical products in 1991 were 3.4% higher...

WORLD MARKETS FOR DRUG DELIVERY

23 March 1992

The world market for drug delivery systems, including new innovations such as carrier-based, controlled-release, transdermal and intranasal delivery, is expected...

US MEDICARE DRUG PILOT TEST PLAN

23 March 1992

The package of proposals passed this month by the US Senate aimed at providing support for the industry tax...

STOCK MARKET COMMENTARY: NEW YORK

23 March 1992

NEW YORK: see-sawed through the reporting week, first down on caution ahead of economic data and interest rate concerns and...

Showing 94591-94600 of 95368 articles